Superworth

Anika Therapeutics price to book ratio ANIK

Market value divided by the book value of the company's net assets, since 2011.

Today, Oct 23, 2026
2.1×
10-year median
1.8×
Against its 10-year history
67th
percentile: 0 is its lowest day, 100 its highest
10-year range
0.8× to 4.0×
Peer median
2.6×

Anika Therapeutics' price to book ratio is 2.1× as of Oct 23, 2026.

That is above its ten-year median of 1.8×, higher than on 67% of days in the last ten years.

Over that time it ranged from 0.8× in Aug 2025 to 4.0× in Oct 2019.

The median for 10 medical instruments and supplies stocks of a similar size is 2.6×.

Price to book ratio over time

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHigh
2026 so far2.1×0.9×2.1×
20250.9×0.8×1.5×
20241.3×1.2×2.0×
20231.2×0.9×1.6×
20221.5×1.1×1.7×
20211.8×1.7×2.4×
20202.3×1.3×2.6×
20192.7×1.6×4.0×
20181.8×1.7×3.9×
20173.1×2.8×3.6×
20163.3×2.7×4.0×
20152.8×2.4×3.8×
20143.3×3.2×4.8×
20134.0×1.4×4.0×
20121.3×1.3×2.4×
20111.4×0.8×1.4×

Against its peers

Companies in Medical - Instruments & Supplies nearest Anika Therapeutics' size, closest first, today.

CompanyPrice to book ratio
ANIKAnika Therapeutics2.1×
INFUInfuSystem4.7×
UTMDUtah Medical Products1.9×
EMBCEmbectan/m
PDEXPro DEX4.2×
TCMDTactile Systems Technology2.4×
MDXGMimedx2.6×
MOVMovado1.4×
KEQUKewaunee Scientific1.3×
IRMDIradimed10.8×
STAAStaar Surgical3.1×
Peer median2.6×

What the price to book ratio tells you

Market value divided by the accounting value of the company's net assets. Below 1 means the market values the business at less than what it owns on paper.

Book value misses brands, software and people, so asset-light companies always look expensive on it. Most useful for banks and industrials.

More on Anika Therapeutics

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.